The Passio pump drainage system is designed for managing malignant pleural effusions and ascites. Credit: Bearpac Medical, LLC/ PRNewswire.

Bearpac Medical has entered a distribution contract with SYNDEO Medical for the Passio pump drainage system.

Under this multi-year exclusive agreement, SYNDEO will have the exclusive rights to market and distribute the Passio system worldwide, excluding the UK and the US.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Passio pump drainage system is intended to enhance fluid management through advanced technology.

It is claimed to be the first digital handheld solution aimed at improving the management of malignant pleural effusions and ascites.

Bearpac Medical president Jay Zimmerman said: “This partnership marks a significant milestone in our mission to improve patient outcomes through innovation.

“SYNDEO Medical’s expertise and international reach make them an ideal partner to bring the Passio pump drainage system to new markets worldwide.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The system features intelligent flow control and operates at lower vacuum pressures compared to traditional drainage devices, and provides a safer and comfortable experience for patients during therapy.

This new approach is said to replace older drainage methods, allowing for hospital-grade precision to be delivered in home settings.

SYNDEO Medical CEO Justin Lampropoulos said: “This agreement aligns seamlessly with SYNDEO Medical’s strategic vision and portfolio.

“As our global presence continues to grow, we are uniquely positioned to collaborate with forward-thinking companies like Bearpac to bring advanced medical solutions to healthcare providers around the world.”

Bearpac is involved in the development of digital drainage solutions, while SYNDEO, which was launched in 2023, develops fully integrated custom procedural solution products.

Together, Bearpac and SYNDEO aim to widen access to the latest solutions that enhance patient care.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact